MedTrace Logo

HPV Message Testing and Social Media Campaign

NCT03747302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1043

Last updated 2022-09-14

Study results available
· View outcomes & findings →

Summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Conditions

Interventions

OTHER

Social Media Message about HPV and HPV vaccine

Messages educate parents with facts about HPV vaccination.

OTHER

Social media message about risk of electronic cigarettes.

Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Norris Cotton Cancer Center

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Ardis L Olson, MD · Trustees of Dartmouth College

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2019-09-09
Completion
2019-09-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03747302 on ClinicalTrials.gov